General principles of antimicrobial therapy

Mayo Clinic Proceedings

Volumn 73, Issue 10, 1998, Pages 995-1006

  Thompson, Rodney L ^a   Wright, Alan J ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; CLOTRIMAZOLE; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; ITRACONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; NYSTATIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ABDOMINAL INFECTION; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; MYCOSIS; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PHYSICAL EXAMINATION; PNEUMONIA; PRACTICE GUIDELINE; SIDE EFFECT;

EID: 0031690488     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.10.995     Document Type: Conference Paper

References (24)

1. Ambrose PG, Owens RC Jr, Quintiliani R, Yeston N, Crowe HM, Cunha BA, et al. Antibiotic use in the critical care unit. Crit Care Clin 1998 Apr;14:283-308
2. Bartlett JG. Intra-abdominal sepsis. Med Clin North Am 1995 May;79:599-617
3. Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs Aging 1997;11:7-18
4. Cunha BA. Antibiotic treatment of sepsis. Med Clin North Am 1995 May; 79:551-558
5. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247-259
6. Espinel-lngroff A. Clinical relevance of antifungal resistance. Infect Dis Clin North Am 1997 Dec;ll:929-944
7. Finch RG, Woodhead MA. Practical considerations and guidelines for the management of community-acquired pneumonia. Drugs 1998;55:3145
8. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997;39:677-686
9. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobialresistant bacteria in hospitals. Infect Dis Clin North Am 1997 Dec;ll:757765
10. Gleason PP, Kapoor WN, Stone RA, Lave JR, Obrosky DS, Schulz R, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 1997;278:32-39
11. Gleckman RA. Antibiotic concerns in the elderly: a clinician's perspective. Infect Dis Clin North Am 1995 Sep;9:575-590
12. Gross PA. The potential for clinical guidelines to impact appropriate antimicrobial agent use. Infect Dis Clin North Am 1997 Dec;ll:803-812
13. Hathorn JW, Lyke K. Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches. Clin Infect Dis 1997;24(Suppl 2):S256-S265
14. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al (Infectious Diseases Society of America). 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997;25:551-573
15. Kibbler CC. Neutropenic infections: strategies for empirical therapy. J Antimicrob Chemother 1995;36(Suppl B):107-117
16. Landman D, Quäle JM. Management of infections due to resistant enterococci: a review of therapeutic options. J Antimicrob Chemother 1997; 40:161-170
17. LiPuma JJ, Stull TL. Antibacterial agents in pediatrics. Infect Dis Clin North Am 1995 Sep;9:561-574
18. Nagata MP, Gentry CA, Hampton EM. Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic Candida infections? Ann Pharmacother 1996;30:811-818
19. Nathwani D. Sequential switch therapy for lower respiratory tract infections: a European perspective. Chest 1998;113(Suppl):211S-218S
20. Ramirez JA. Switch therapy with beta-lactam/beta-lactamase inhibitors in patients with community-acquired pneumonia. Ann Pharmacother 1998;32(Suppl):S22-S26
21. Rybak MJ, McGrath BJ. Combination antimicrobial therapy for bacterial infections: guidelines for the clinician. Drugs 1996:52:390-405
22. Schentag JJ, Birmingham MC, Paladino JA, Carr JR, Hyatt JM, Forrest A, et al. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Semin Respir Infect 1997;12:278-293
23. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, et al (American Heart Association). Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995;274:1706-1713
24. Wittmann DH, Schein M. Let us shorten antibiotic prophylaxis and therapy in surgery. Am J Surg 1996;172(Suppl 6A):26S-32S